Corporativo Fragua S.A.B. stock (MXP339891039): Mexican pharmacy chain trades at a discount to peers on BMV

Corporativo Fragua S.A.B. shares trade on the Bolsa Mexicana de Valores under the ticker FRAGUAB, with a valuation below many Mexican retail peers despite steady pharmacy operations.

Shares of Corporativo Fragua S.A.B. de C.V., the parent of Farmacias Guadalajara, trade on the Bolsa Mexicana de Valores under the ticker FRAGUAB, with a current price around 482 pesos per share as of early May 2026, according to market data from Investing.com MX Investing.com MX as of 05/10/2026.

At that level, the stock trades at a price–earnings ratio of about 10.8 times trailing earnings, below the peer group average of roughly 18.9 times and the broader non?cyclical consumer sector average of about 12.2 times, according to the same source Investing.com MX as of 05/10/2026. The price–to?sales ratio of about 0.4 times also sits below both the peer and sector medians, suggesting a relatively conservative valuation for the Mexican pharmacy chain.

As of: 10.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Corporativo Fragua S.A.B. de C.V.
• Sector/industry: Consumer non?cyclical / pharmacy retail
• Headquarters/country: Mexico
• Core markets: Mexico
• Key revenue drivers: Pharmacy and health?care retail, over?the?counter products, basic consumer goods
• Home exchange/listing venue: Bolsa Mexicana de Valores (BMV), ticker FRAGUAB
• Trading currency: Mexican peso

Corporativo Fragua S.A.B.: core business model

Corporativo Fragua S.A.B. de C.V. operates through its main brand Farmacias Guadalajara, one of Mexico’s largest pharmacy chains, with hundreds of locations across the country Farmacias Guadalajara as of 05/10/2026. The company focuses on retail pharmacy services, prescription dispensing, and a broad range of health?related and everyday consumer products.

The business model combines high?volume, low?margin pharmacy sales with higher?margin over?the?counter medicines, personal?care items, and basic household goods, which helps stabilize cash flow even in periods of economic pressure Farmacias Guadalajara as of 05/10/2026. Fragua also leverages private?label products and promotional campaigns to maintain customer traffic and loyalty.

Main revenue and product drivers for Corporativo Fragua S.A.B.

Pharmacy and health?care products represent the largest share of Fragua’s revenue, supported by Mexico’s growing population and rising demand for accessible health services Farmacias Guadalajara as of 05/10/2026. The company benefits from recurring customer visits for prescriptions and chronic?disease medications, which tend to be less sensitive to short?term economic swings.

In addition to core pharmacy sales, Fragua generates meaningful revenue from beauty and personal?care items, baby products, and basic groceries, which are often purchased alongside prescriptions Farmacias Guadalajara as of 05/10/2026. Seasonal campaigns, such as Mother’s Day promotions highlighted on the company’s website, help drive short?term spikes in traffic and basket size.

Conclusion

Corporativo Fragua S.A.B. operates a large pharmacy?retail network in Mexico, serving a broad base of consumers with health?care and everyday goods Farmacias Guadalajara as of 05/10/2026. The stock trades at a valuation discount to many Mexican retail peers, which may reflect both sector?wide pressures and company?specific factors such as competition and margin dynamics.

For US investors, the main exposure comes through the Mexican consumer and health?care sectors, which are sensitive to local economic conditions, currency movements, and regulatory changes Investing.com MX as of 05/10/2026. While the current valuation appears relatively conservative, investors would need to weigh these macro and competitive risks against the company’s established store footprint and recurring customer base.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.